Ali Hakan Kaya

Spesialisasi: Hematologist
20 tahun pengalaman
Berbahasa:
English
Tempat kerja: Turquia, Istambul, Biruni University Hospital
Memenangkan Juara Pertama untuk makalah dari Asosiasi Transplantasi Darah dan Sumsum Tulang pada tahun 2017.
Dr. Ali Hakan Kaya adalah seorang hematolog di Rumah Sakit Universitas Biruni di Istanbul. Beliau memenangkan juara pertama dari Asosiasi Transplantasi Darah dan Sumsum Tulang atas penelitiannya. Dr. Kaya berspesialisasi dalam transplantasi sel punca dan pengobatan kanker darah yang kompleks. Beliau bekerja di rumah sakit universitas yang terakreditasi TEMOS dan dilengkapi dengan departemen hematologi-onkologi khusus.
- Melakukan transplantasi sumsum tulang alogenik dari donor yang memiliki hubungan kekerabatan maupun tidak.
- Mengobati leukemia, mieloma, dan berbagai jenis limfoma menggunakan terapi sel CAR T.
- Merupakan anggota Masyarakat Afaresis Turki dan Masyarakat Onkologi Hematologi.
- Menerima berbagai penghargaan atas makalah ilmiahnya tentang imunologi hematologi dan onkologi.

Layanan dokter

Lihat lagi

Bagaimana pelayanan kami?

1 dari 3

Informasi tentang dokter ini lengkap dan jelas.

Sangat tidak setuju

Sangat setuju

Kualifikasi

Dr. Ali Hakan Kaya is an Associate Professor specializing in hematology and stem cell transplantation at Biruni University Hospital. He won First Prize from the Blood and Bone Marrow Transplantation Association in 2017. Dr. Kaya holds multiple awards for his scientific research in hematologic oncology and immunology.

Specialization and Hematologic Care

Dr. Kaya treats adult blood cancers and disorders. He performs bone marrow and stem cell transplantations. These procedures include allogenic transplants from both related and unrelated donors. He also uses haploidentical techniques to expand donor options for patients.

The doctor treats various conditions:

Leukemia (AML and ALL)
Multiple Myeloma
Hodgkin's and Non-Hodgkin's lymphoma
Burkitt's and Follicular lymphoma
Aplastic anemia
Thrombocytopenia

Dr. Kaya uses CAR T-cell therapy for advanced cases. CAR T-cell therapy is a treatment where a patient's immune cells are reprogrammed to attack cancer. He also provides chemotherapy and biological therapy protocols. As part of his diagnostic work, he performs bone marrow biopsies and immunohistochemistry.

Work Experience

2022–2024 – Associate Professor, Istanbul VM Medical Park Pendik Hospital
2021–2024 – Associate Professor, Maltepe University Faculty of Medicine
2019–2021 – Associate Professor, Istanbul Ümraniye Training and Research Hospital
2018–2019 – Hematology Subspecialist, Istanbul Ümraniye Training and Research Hospital
2017–2018 – Hematology Subspecialist, Ankara Gülhane Training and Research Hospital
2013–2017 – Subspecialty Training, Ankara Oncology Training and Research Hospital
2012–2013 – Internal Medicine Specialist, Samsun Military Hospital
2010–2012 – Internal Medicine Specialist, Istanbul Esenyurt State Hospital
2006–2010 – Assistant Doctor, Istanbul Haseki Training and Research Hospital

Education and Training

2019 – Earned Associate Professor title at Istanbul Ümraniye Training and Research Hospital
2017 – Completed Hematology Subspecialty at Ankara Oncology Training and Research Hospital
2010 – Completed Internal Medicine Residency at Istanbul Haseki Training and Research Hospital
2005 – Graduated from Cerrahpaşa Faculty of Medicine, Istanbul University